HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,028 shares of the company’s stock after purchasing an additional 800 shares during the quarter. Thompson Siegel & Walmsley LLC’s holdings in HCA Healthcare were worth $6,514,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Terra Nova Asset Management LLC grew its position in shares of HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock valued at $3,297,000 after purchasing an additional 26 shares during the period. Massmutual Trust Co. FSB ADV boosted its stake in shares of HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after acquiring an additional 29 shares during the last quarter. Waldron Private Wealth LLC boosted its stake in HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after purchasing an additional 29 shares during the last quarter. Brookstone Capital Management boosted its position in HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after acquiring an additional 30 shares during the last quarter. Finally, UMB Bank n.a. boosted its holdings in shares of HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after purchasing an additional 30 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 0.2 %

Shares of HCA stock opened at $332.22 on Friday. The business’s fifty day moving average price is $380.80 and its 200 day moving average price is $357.94. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm has a market capitalization of $84.15 billion, a PE ratio of 14.92, a P/E/G ratio of 1.29 and a beta of 1.68. HCA Healthcare, Inc. has a 1-year low of $245.84 and a 1-year high of $417.14.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.79%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 21.97 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,155 shares of company stock valued at $5,608,990. Insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of several recent analyst reports. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. TD Cowen decreased their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Wells Fargo & Company upped their price target on HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 6th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Finally, UBS Group increased their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.